» Articles » PMID: 32635462

Signaling Pathways That Control Muscle Mass

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Jul 9
PMID 32635462
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

The loss of skeletal muscle mass under a wide range of acute and chronic maladies is associated with poor prognosis, reduced quality of life, and increased mortality. Decades of research indicate the importance of skeletal muscle for whole body metabolism, glucose homeostasis, as well as overall health and wellbeing. This tissue's remarkable ability to rapidly and effectively adapt to changing environmental cues is a double-edged sword. Physiological adaptations that are beneficial throughout life become maladaptive during atrophic conditions. The atrophic program can be activated by mechanical, oxidative, and energetic distress, and is influenced by the availability of nutrients, growth factors, and cytokines. Largely governed by a transcription-dependent mechanism, this program impinges on multiple protein networks including various organelles as well as biosynthetic and quality control systems. Although modulating muscle function to prevent and treat disease is an enticing concept that has intrigued research teams for decades, a lack of thorough understanding of the molecular mechanisms and signaling pathways that control muscle mass, in addition to poor transferability of findings from rodents to humans, has obstructed efforts to develop effective treatments. Here, we review the progress made in unraveling the molecular mechanisms responsible for the regulation of muscle mass, as this continues to be an intensive area of research.

Citing Articles

Polyunsaturated Fatty Acids and Reduced Risk of Low Muscle Mass in Adults.

Zou H, Zheng L, Zeng C Nutrients. 2025; 17(5).

PMID: 40077720 PMC: 11902165. DOI: 10.3390/nu17050858.


Skeletal muscle growth to combat diabetes and obesity: the potential role of muscle-secreted factors.

Sammut M, Thorne B, Melling C Obesity (Silver Spring). 2025; 33(3):435-451.

PMID: 39948829 PMC: 11897867. DOI: 10.1002/oby.24223.


Associations between sedentary behaviour and sarcopenia among patients aged 40 and older with chronic obstructive pulmonary disease: a cross-sectional study.

Wang D, Zhang M, Huang J, Zhang H, Chen S, Wang K BMC Public Health. 2025; 25(1):366.

PMID: 39881257 PMC: 11776302. DOI: 10.1186/s12889-025-21450-y.


Sarcopenia and Cardiogeriatrics: The Links Between Skeletal Muscle Decline and Cardiovascular Aging.

Anagnostou D, Theodorakis N, Hitas C, Kreouzi M, Pantos I, Vamvakou G Nutrients. 2025; 17(2).

PMID: 39861412 PMC: 11767851. DOI: 10.3390/nu17020282.


Role of Abscisic Acid in the Whole-Body Regulation of Glucose Uptake and Metabolism.

Spinelli S, Humma Z, Magnone M, Zocchi E, Sturla L Nutrients. 2025; 17(1.

PMID: 39796447 PMC: 11723322. DOI: 10.3390/nu17010013.


References
1.
Ryu D, Mouchiroud L, Andreux P, Katsyuba E, Moullan N, Nicolet-Dit-Felix A . Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat Med. 2016; 22(8):879-88. DOI: 10.1038/nm.4132. View

2.
Kline W, Panaro F, Yang H, Bodine S . Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. J Appl Physiol (1985). 2006; 102(2):740-7. DOI: 10.1152/japplphysiol.00873.2006. View

3.
Lee D, Takayama S, Goldberg A . ZFAND5/ZNF216 is an activator of the 26S proteasome that stimulates overall protein degradation. Proc Natl Acad Sci U S A. 2018; 115(41):E9550-E9559. PMC: 6187164. DOI: 10.1073/pnas.1809934115. View

4.
Goncalves D, Silveira W, Manfredi L, Graca F, Armani A, Bertaggia E . Insulin/IGF1 signalling mediates the effects of β -adrenergic agonist on muscle proteostasis and growth. J Cachexia Sarcopenia Muscle. 2019; 10(2):455-475. PMC: 6463755. DOI: 10.1002/jcsm.12395. View

5.
Shimizu N, Yoshikawa N, Ito N, Maruyama T, Suzuki Y, Takeda S . Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab. 2011; 13(2):170-82. DOI: 10.1016/j.cmet.2011.01.001. View